glp 1 유사체 GLP-1A 첫 비만약 '삭센다', 국내 허가 < 제약·바이오 < 산업 < 기사본문 동향리포트]GLP-1 수용체 작용제: 당뇨병 치료에서

In our previous studies, a multivalent epitope vaccine FVpE containing NAP, three fragments from CagA and VacA, and urease multi-epitope peptide (UE) from the urease multi-epitope vaccine CTB-UE ( H

Retatrutide was nicknamed "triple-G" due to its activation of three hormones: GLP-1, GIP and glucagon

DNA Double-Strand Break-Related competitive endogenous RNA network of noncoding RNA in bovine cumulus cells [J]

Often, people don't get the results that they want because they take random amounts whenever they remember

Its key feature lies in the competitive utilization of the same substrate by iNOS (also known as Nos2) and Arg1: the former generates NO and is closely associated with pro-inflammatory effects, whereas the latter produces ornithine and polyamines and participates in tissue repair and immune regulation ( Under classical pro-inflammatory stimulation (such as LPS/IFN-), iNOS expression is upregulated and catalyzes the conversion of Arg into NO and citrulline